Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells
about
Role of MRP transporters in regulating antimicrobial drug inefficacy and oxidative stress-induced pathogenesis during HIV-1 and TB infectionsCan nanomedicines kill cancer stem cells?Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemiaPhotodynamic therapy: one step ahead with self-assembled nanoparticlesPluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiersFormulation and characterization of echogenic lipid-Pluronic nanobubblesEffects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers.The utilization of pathogen-like cellular trafficking by single chain block copolymerDegradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.A Novel Docetaxel-Loaded Poly (ε-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment.Pluronics and MDR reversal: an update.Matrix metalloproteinase-sensitive thermogelling polymer for bioresponsive local drug delivery.Reversing multidrug resistance in Caco-2 by silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL using liposomal antisense oligonucleotides.Thermo-sensitive liposomes loaded with doxorubicin and lysine modified single-walled carbon nanotubes as tumor-targeting drug delivery system.Polymer genomics: an insight into pharmacology and toxicology of nanomedicinespH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours.Salubrinal-Mediated Upregulation of eIF2α Phosphorylation Increases Doxorubicin Sensitivity in MCF-7/ADR Cells.Block copolymer micelles as delivery vehicles of hydrophobic drugs: micelle-cell interactions.Pluronic mixed micelles overcoming methotrexate multidrug resistance: in vitro and in vivo evaluation.HPMA copolymer-bound doxorubicin induces apoptosis in ovarian carcinoma cells by the disruption of mitochondrial function.Different internalization pathways of polymeric micelles and unimers and their effects on vesicular transportDoxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancerNanomedicinal strategies to treat multidrug-resistant tumors: current progress.Interfacing materials science and biology for drug carrier design.A cell-based pharmacokinetics assay for evaluating tubulin-binding drugsDoxorubicin-loaded PEG-PCL copolymer micelles enhance cytotoxicity and intracellular accumulation of doxorubicin in adriamycin-resistant tumor cells.Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs.In vitro and in vivo evaluation of paclitaxel-lapatinib-loaded F127 pluronic micelles.Nanostructured lipid-carrageenan hybrid carriers (NLCCs) for controlled delivery of mitoxantrone hydrochloride to enhance anticancer activity bypassing the BCRP-mediated efflux.Precious metal carborane polymer nanoparticles: characterisation of micellar formulations and anticancer activity.Glucose transporter and folic acid receptor-mediated Pluronic P105 polymeric micelles loaded with doxorubicin for brain tumor treating.The DNA methyl transferase inhibitor, 5'-aza-2-deoxycitidine, enhances the apoptotic effect of Mevastatin in human leukemia HL-60 cells.The influence of Pluronics® on dark cytotoxicity, photocytotoxicity, localization and uptake of curcumin in cancer cells: studies of curcumin and curcuminoids XLIX.Relationship between the affinity of PEO-PPO-PEO block copolymers for biological membranes and their cellular effects.Enhanced in vitro cellular uptake of P-gp substrate by poloxamer-modified liposomes (PMLs) in MDR cancer cells.Hydrocinchonine, cinchonine, and quinidine potentiate paclitaxel-induced cytotoxicity and apoptosis via multidrug resistance reversal in MES-SA/DX5 uterine sarcoma cells.Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers.Non-viral cancer gene therapy: beyond delivery.
P2860
Q26781386-4060D4AF-3905-40C7-9B4C-3D3573DAE74CQ27022017-9E7C7B33-70DE-4081-A42C-8584F61D8FE3Q27309004-8657B3CA-E408-445D-90BE-1B1A79C1DEEFQ28083513-B4A2C928-E123-48AC-9720-262E9C398D43Q28282826-846DED3D-EC60-4B30-B702-E33A56F94C0AQ30470286-074F4475-7B9D-4EB0-8ECC-0D5F9C8EB7B1Q30475533-B2BFE716-098A-40D1-840A-D62EE05196E3Q30499330-BE2A8266-FA79-4CAD-B34A-BF274707E78CQ33902253-67C8F571-902E-4BB0-BB11-74ECD5F49930Q33949801-ED51F13E-4D01-4AC9-B02C-BDC188CF3B54Q34005678-EB1065A0-9D3B-4139-BDD4-D2F45E3907A2Q34858832-4C3130E7-9A5D-4618-9FD8-CCEFB438BEC7Q35122908-E2E626AB-C69D-4A96-87A6-A5A2DD4ABF9BQ35208433-60559709-43C9-4E88-8DB8-4A0EC7FE5914Q35754353-221A3D02-8B32-499D-9797-4C34593199C0Q35934993-9B2D5762-66AB-43D7-BACE-78DA8553FE6FQ36327049-478A0123-823F-4647-BB84-A46FC4C26D9AQ36591295-0536BC96-737F-45C0-BCFD-D982ADDC5262Q36648447-16B8FA51-7C56-4411-8108-BEAB958B8203Q36779964-00E35ECB-3BCE-43FF-98A1-B282DA4F452AQ36893877-AD92D4C8-20BE-4590-82E6-9E8111FBED53Q36953871-1BEC44F0-721F-4722-873E-30310FA1FD26Q37378180-C7C3B13C-7C33-402B-BFF8-64E3DA746AB5Q37383842-C793A28C-A36A-43FE-8715-F2E95AC97D84Q37763152-C0E35A4C-0300-401B-803D-F031B73EA745Q38366527-710C3BC7-27FB-40FD-811D-41EE1009045DQ38561970-802DB6C3-7911-423E-BDC2-2D5FDFEC7B36Q38572202-D03CD184-5F24-439D-8C07-519EB49C9DCCQ38588547-1E195312-AA61-4F85-80F4-19E499667068Q38735063-A826D491-DB3C-43E5-BB90-76825133E892Q38804702-ED5E5069-9DEF-46F4-A7B4-6BBFEE4F6DE2Q38951818-834A7124-3220-49B7-9441-A6EE5014136AQ38997366-5F403FB4-91A7-44A0-839A-8F2924C36D35Q39114798-9D53D3F3-CD19-4A47-B4E9-EE6DF91E6680Q39251867-65BAE5C6-6BA8-4BE4-B53A-3B16C291B0A5Q39384996-FC1DA82E-0280-4093-B947-09953CA86143Q39504361-AF6870EA-843E-412F-A030-06E4AB7481A6Q39733379-8A988EF7-48EF-434B-BF3D-91213300343BQ39789933-E3F702A9-6AF7-4AA4-8584-567BA9B5619DQ44242183-40236525-49FC-441D-A2F5-1224ECCFFF28
P2860
Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pluronic block copolymers alte ...... in drug-resistant cancer cells
@en
Pluronic block copolymers alte ...... n drug-resistant cancer cells.
@nl
type
label
Pluronic block copolymers alte ...... in drug-resistant cancer cells
@en
Pluronic block copolymers alte ...... n drug-resistant cancer cells.
@nl
prefLabel
Pluronic block copolymers alte ...... in drug-resistant cancer cells
@en
Pluronic block copolymers alte ...... n drug-resistant cancer cells.
@nl
P2093
P2860
P1476
Pluronic block copolymers alte ...... in drug-resistant cancer cells
@en
P2093
Alexander V Kabanov
Elena V Batrakova
Refika I Pakunlu
Valery Yu Alakhov
P2860
P304
P356
10.1016/J.JCONREL.2005.03.019
P407
P50
P577
2005-07-01T00:00:00Z